Financial results Vaxcyte from 11/11/21

News editor
press@blackterminal.com

Vaxcyte's GAAP loss for 9M 2021 was $71.514 million, up 4.4% from $68.48 million in the prior year.

Vaxcyte

PCVX

$89.64

+1.41%

Review

Source:

{source} pictogram

investors.vaxcyte.com

News editor

News feed

YUGK's state-owned stake will be sold at an open auction

12/30/25 UGLD

EMC buys the Skandinavia clinic chain

12/29/25 GEMC

EMC Board of Directors proposed to place 32.8 million additional shares

12/29/25 GEMC

Fix Price bought back 29.5 million shares as part of buyback

12/29/25 FIXR

MD Medical has acquired a building for a new hospital in Moscow

12/29/25 MDMG

Promomed entered the Uzbek market with its Ozempika counterpart

12/29/25 PRMD

Tyumen Motor Builders will repay treasury shares and make an additional issue

12/29/25 TUMN

Catalytic People acquired 25% of Selectel

12/29/25 T

Shareholders of EL5-Energo approved the merger of JSC VDK-Energo and LLC LUKOIL-Ekoenergo

12/29/25 ELFV

Shareholders of T-Technologies approved dividends

12/29/25 T